Weikang Bio-Tech (PINK:WKBT)

GeoProfile
Overview
Facility Tour
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders

Do you represent this company?

Learn how we can help increase your exposure to investors.

All Research Analyst Reports Articles Auditor trail Comments & Business Outlook Conference Call Notes Deal Flow Financial Target Agreements GeoSpecial Notes Interviews Investor Alert Investor Presentations Legal Insights Liquidity Requirements Share Structure Special Situations

Wednesday, January 19, 2011

LINCOLN, Neb., Jan. 19, 2011 (GLOBE NEWSWIRE) -- A research update report has been issued by Market Advisors, Inc. "Fundamental Analysis for Today's Investments" on Weikang Bio-Technology Group Company, Inc. .

According to the report, The Company expects to announce the fiscal year ended 12-31-10 net revenues of $77.8 million, which is a 64% increase from last year's $47.5 million reported for fiscal year 2009. WKBT expects to report net income of $31.2 million, which is a 100% increase from $15.6 million for fiscal 2009, and earnings per share of $1.04. Our intermediate term target price is $6.05.

Permalink